NCT04758845

Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults

A Randomized, 5 Arm, Parallel, Placebo Controlled Clinical Study to Evaluate Safety and Efficacy of New Probiotic Strains in Healthy Adults

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 125 (estimated)
• Sponsor: Deerland Enzymes · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This trial is to determine the safety of 4 new probiotic strains and to assess their efficacy in reducing the incidence and/or duration of gastrointestinal problems and infections as well as respiratory infections in healthy adults.

Conditions

• Gastrointestinal Health
• Respiratory Health
• Safety

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Cocktail	Subjects will consume 2B CFU once daily containing .5B CFU DE111, .5B CFU MIT411, .5B CFU CGI314, and .5B CFU CSI08 for 45 days.
DIETARY_SUPPLEMENT	CGI314	Subjects will consume 1B CFU of CGI314 once daily for 45 days.
DIETARY_SUPPLEMENT	CSI08	Subjects will consume 1B CFU of CSI08 once daily for 45 days.
DIETARY_SUPPLEMENT	MIT411	Subjects will consume 1B CFU of MIT411 once daily for 45 days.

Timeline

• Start date: 2021-02-11
• Primary completion: 2021-04-01
• Completion: 2021-05-01
• First posted: 2021-02-17
• Last updated: 2021-02-17

Locations

1 site across 1 country: Slovenia